Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 571

1.

Next-generation sequencing in the clinic: promises and challenges.

Xuan J, Yu Y, Qing T, Guo L, Shi L.

Cancer Lett. 2013 Nov 1;340(2):284-95. doi: 10.1016/j.canlet.2012.11.025. Epub 2012 Nov 19. Review.

2.

Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution.

Patel LR, Nykter M, Chen K, Zhang W.

Cancer Lett. 2013 Nov 1;340(2):152-60. doi: 10.1016/j.canlet.2012.10.018. Epub 2012 Oct 27. Review.

3.

Analyzing the cancer methylome through targeted bisulfite sequencing.

Lee EJ, Luo J, Wilson JM, Shi H.

Cancer Lett. 2013 Nov 1;340(2):171-8. doi: 10.1016/j.canlet.2012.10.040. Epub 2012 Nov 28. Review.

4.

Identifying molecular drivers of gastric cancer through next-generation sequencing.

Liang H, Kim YH.

Cancer Lett. 2013 Nov 1;340(2):241-6. doi: 10.1016/j.canlet.2012.11.029. Epub 2012 Nov 20. Review.

5.

Cancer omics: from regulatory networks to clinical outcomes.

Tang B, Hsu PY, Huang TH, Jin VX.

Cancer Lett. 2013 Nov 1;340(2):277-83. doi: 10.1016/j.canlet.2012.11.033. Epub 2012 Nov 29. Review.

PMID:
23201140
6.

Genomic sequencing in cancer.

Tuna M, Amos CI.

Cancer Lett. 2013 Nov 1;340(2):161-70. doi: 10.1016/j.canlet.2012.11.004. Epub 2012 Nov 23. Review.

7.

Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.

Liu X, Wang J, Chen L.

Cancer Lett. 2013 Nov 1;340(2):270-6. doi: 10.1016/j.canlet.2012.11.002. Epub 2012 Nov 12. Review.

PMID:
23153794
8.

Genome-wide sequencing to identify the cause of hereditary cancer syndromes: with examples from familial pancreatic cancer.

Roberts NJ, Klein AP.

Cancer Lett. 2013 Nov 1;340(2):227-33. doi: 10.1016/j.canlet.2012.11.008. Epub 2012 Nov 27. Review.

9.

Understanding genomic alterations in cancer genomes using an integrative network approach.

Wang E.

Cancer Lett. 2013 Nov 1;340(2):261-9. doi: 10.1016/j.canlet.2012.11.050. Epub 2012 Dec 22. Review.

PMID:
23266571
10.

Sequencing technologies and genome sequencing.

Pareek CS, Smoczynski R, Tretyn A.

J Appl Genet. 2011 Nov;52(4):413-35. doi: 10.1007/s13353-011-0057-x. Epub 2011 Jun 23. Review.

11.

Validation of the Oncomine focus panel for next-generation sequencing of clinical tumour samples.

Williams HL, Walsh K, Diamond A, Oniscu A, Deans ZC.

Virchows Arch. 2018 Oct;473(4):489-503. doi: 10.1007/s00428-018-2411-4. Epub 2018 Aug 13.

12.

Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.

Paolillo C, Londin E, Fortina P.

Scand J Clin Lab Invest Suppl. 2016;245:S84-91. doi: 10.1080/00365513.2016.1210331. Epub 2016 Aug 17.

PMID:
27542004
13.

Ten years of next-generation sequencing technology.

van Dijk EL, Auger H, Jaszczyszyn Y, Thermes C.

Trends Genet. 2014 Sep;30(9):418-26. doi: 10.1016/j.tig.2014.07.001. Epub 2014 Aug 6. Review.

PMID:
25108476
14.

Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.

Sasaki Y, Tamura M, Koyama R, Nakagaki T, Adachi Y, Tokino T.

World J Gastroenterol. 2016 Feb 21;22(7):2284-93. doi: 10.3748/wjg.v22.i7.2284. Review.

15.

Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.

Kamps R, Brandão RD, Bosch BJ, Paulussen AD, Xanthoulea S, Blok MJ, Romano A.

Int J Mol Sci. 2017 Jan 31;18(2). pii: E308. doi: 10.3390/ijms18020308. Review.

16.

Lake Louise mutation detection meeting 2013: clinical translation of next-generation sequencing requires optimization of workflows and interpretation of variants.

Smith A, Boycott KM, Jarinova O.

Hum Mutat. 2014 Feb;35(2):265-9. doi: 10.1002/humu.22480. Epub 2013 Nov 27.

PMID:
24282140
17.

Understanding next generation sequencing in oncology: A guide for oncologists.

Moorcraft SY, Gonzalez D, Walker BA.

Crit Rev Oncol Hematol. 2015 Dec;96(3):463-74. doi: 10.1016/j.critrevonc.2015.06.007. Epub 2015 Jun 29. Review.

PMID:
26160606
18.

Next generation sequencing applications in cancer research.

Zhang W, Nykter M, Chen K.

Cancer Lett. 2013 Nov 1;340(2):149-50. doi: 10.1016/j.canlet.2013.05.026. Epub 2013 Jun 11. No abstract available.

PMID:
23764479
19.

Cancer heterogeneity and "the struggle for existence": diagnostic and analytical challenges.

Horswell S, Matthews N, Swanton C.

Cancer Lett. 2013 Nov 1;340(2):220-6. doi: 10.1016/j.canlet.2012.10.031. Epub 2012 Nov 8. Review.

PMID:
23142290
20.

Advances for studying clonal evolution in cancer.

Ding L, Raphael BJ, Chen F, Wendl MC.

Cancer Lett. 2013 Nov 1;340(2):212-9. doi: 10.1016/j.canlet.2012.12.028. Epub 2013 Jan 23. Review.

Supplemental Content

Support Center